PROFFERED PAPERS
Monday, March 22   —  8:00 AM   —  Harding


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




Section H1 - Endocrine Pathology
Chaired By: Ronald Ghossein and Tamar Giorgadze



TimeTitle and AuthorsItinerary
Planner
8:00 Molecular Genotyping of Papillary Thyroid Carcinoma Follicular Variant According to Its Histologic Subtypes (Encapsulated vs Non-Encapsulated Infiltrative) Reveals Distinct BRAF and RAS Mutation Patterns (583)
M Rivera, J Ricarte-Filho, J Knauf, RM Tuttle, J Fagin, R Ghossein. - Memorial Sloan-Kettering Cancer Center, NY.
Add
8:15 A Combined Molecular-Pathological Score To Predict Aggressiveness of Thyroid Papillary Microcarcinoma (578)
LA Niemeier, HA Kuffner, S Carty, AF Stewart, YE Nikiforov. - UPMC, Pittsburgh, PA.
Add
8:30 Sampling, Assessment, and Reporting of Thyroid Follicular Lesions: Survey of 165 Pathologists (567)
OK Kolman, PM Sadow, JL Hunt. - Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Add
8:45 MicroRNA Expression Abnormalities in Pituitary Adenomas are Associated with Distinctive Pathologic Features and May Contribute to Tumorigenesis (582)
ZR Qian, T Tanahashi, K Yoshimoto, S Yamada, S Katsuura, EL Wang, K Rokutan, T Sano. - Institute of Health Biosciences, University of Tokushima, Tokushima, Japan; Toranomon Hospital, Tokyo, Japan.
Add
9:00 Increased Expression of Ribonucleotide Reductase Subunit M2 in Adrenal Cortical Carcinoma: Possible Mechanism of Chemoresistance (574)
J Lin, DG Thomas, TJ Giordano. - University of Michigan, Ann Arbor, MI.
Add
9:15 Grade Progression of Well Differentiated Neuroendocrine Tumors (WDNETs) of the Enteropancreatic System Is Distinct from Poorly Differentiated (PD) High Grade Neuroendocrine Carcinomas (PDHGNECas) (587)
LH Tang, L Song, J Shia, E Vakiani, DS Klimstra. - Memorial Sloan-Kettering Cancer Center, New York, NY.
Add
9:30 RECESS, EXHIBITS, POSTER SESSION I